• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GALDERMA Q-MED SCULPTRA AESTHETIC; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GALDERMA Q-MED SCULPTRA AESTHETIC; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Lot Number A8137
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Rash (2033); Swelling (2091); Dizziness (2194); Urticaria (2278); No Code Available (3191)
Event Date 10/01/2019
Event Type  Injury  
Manufacturer Narrative
Manufacturer narrative: the reported lot number was valid.Capa comment: the information in this single case does not suggest involvement of a nonconforming product or quality problem and will not initiate a corrective or preventive action.Pharmacovigilance comment: the serious event of anaphylactic reaction was considered expected and possibly related to the treatment.Serious criteria included the need for urgent medical care, and treatment with epinephrine, steroids and anti-histamines.The non-serious expected events of dizziness, pruritus, rash and hives and unexpected event of peripheral swelling were considered possibly related to the treatment and are consistent with the diagnosis of anaphylaxis.Potential contributory factors include concomitant treatments with botulinum toxin and lidocaine.The case meets the criteria for expedited reporting to the regulatory authorities.
 
Event Description
Case reference number (b)(4) is a spontaneous report sent on 07-oct-2019 by a physician which refers to a female aged (b)(6) years.The patient had no significant medical history and no known drug allergy.The patient was not on any routine medications.The patient had not received any filler treatments in the past.Concomitant treatment included lidocaine [lidocaine] and botox [botox] injection on (b)(6) 2019.On (b)(6) 2019, the patient received treatment with 8 ml total of sculptra aesthetic (lot a8137) mixed with lidocaine to cheek area, jawline and right temple (unknown injection technique and needle type) for an unknown indication.15 minutes later, on (b)(6) 2019, the patient experienced lightheaded (dizziness).The healthcare professional assisted the patient into a lying down position.Soon after, the patient started having and itching (pruritus) and rash (rash) that turned into hives (urticaria), spread all over her body.The patient also had swollen hands (peripheral swelling).The patient was injected with kenalog [triamcinolone acetonide] intramuscularly by healthcare professional and also given oral benadryl [diphenhydramine hydrochloride].The patient went to emergency room and was told she was having an anaphylactic reaction (anaphylactic reaction).The patient was given epinephrine [epinephrine] and unspecified steroids.On (b)(6) 2019, the injecting physician spoke with the patient who reported that she was still experiencing itching and rash.Outcome at the time of the report: anaphylactic reaction was not recovered/not resolved.Lightheaded was recovered/resolved.Itching was not recovered/not resolved.Swollen hands was recovered/resolved.Hives was not recovered/not resolved.Rash was not recovered/not resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SCULPTRA AESTHETIC
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
GALDERMA Q-MED
seminariegatan 21
uppsala, SE-75 2 28
SW  SE-752 28
Manufacturer (Section G)
GALDERMA Q-MED
seminariegatan 21
uppsala, SE-75 2 28
SW   SE-752 28
Manufacturer Contact
amy poteate
14501 north freeway
fort worth, TX 76177
8175615353
MDR Report Key9215417
MDR Text Key170792894
Report Number9710154-2019-00092
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030050/S2
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 10/21/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/21/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Lot NumberA8137
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/07/2019
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age65 YR
-
-